Vol 28, No 2 (2021)
Letter to the Editor
Published online: 2021-02-27

open access

Page views 1836
Article views/downloads 2760
Get Citation

Connect on Social Media

Connect on Social Media

Post-COVID-19 heart syndrome

Aleksandra Gasecka12, Michał Pruc3, Katarzyna Kukula34, Natasza Gilis-Malinowska5, Krzysztof J. Filipiak1, Milosz J. Jaguszewski5, Lukasz Szarpak46
Pubmed: 33645626
Cardiol J 2021;28(2):353-354.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020; 126(10): 1443–1455.
  2. Gąsecka A, Filipiak KJ, Jaguszewski MJ. Impaired microcirculation function in COVID-19 and implications for potential therapies. Cardiol J. 2020; 27(5): 485–488.
  3. Lindner D, Fitzek A, Bräuninger H, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020; 5(11): 1281–1285.
  4. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265–1273.
  5. Eiros R, Barreiro-Perez M, Martin-Garcia A, et al. Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. .
  6. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270): 220–232.
  7. Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020; 27(5): 489–496.
  8. Li G, Saguner AM, An J, et al. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Cardiol J. 2020; 27(5): 616–624.